-
-
-
-
-
-
-
POINT Biopharma (PNT) Confirms no Supply Shortages of 177Lu-PNT2002 for the SPLASH Trial
-
-
-
-
-
-
-
POINT Biopharma (PNT) Announces Abstract Publication of Dosimetry Data Findings from the Lead-In Cohort of the SPLASH trial in mCRPC at the 2022 SNMMI Mid-Winter & ACNM Annual Meeting
-
-
-
-
-
-
-
POINT Biopharma Adds Senior BD Expertise with Appointment of Dr. Matthew Vincent as SVP, Business Development
-
-
-
-
-
-
-
POINT Biopharma and IONETIX Announce Ac-225 Supply Agreement
-
66,406 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

